Medtech startup brings Oracle AI to bear on cancer drug research | Computer Weekly
Briefly

"I was interested in technology and entrepreneurship and that was my field. Initially, I had no relationship to cancer. But when it happened, I learned a lot."
"With the technology being developed and used at Imagene AI, we may be on the verge of big change. Imagene and its founder and CEO Dean Bitan are hoping to kickstart the process of drug discovery."
Read at ComputerWeekly.com
[
|
]